Short-course radiotherapy plus olaparib for newly diagnosed in patients unsuitable for radical chemoradiation: a randomised phase II clinical trial preceded by a lead-in phase I dose escalation study.
Date added:
16th August 2015
Open/Closed:
Open
Trial ends:
October 2018
Provider
Cancer Research UK Clinical Trials Unit Glasgow
Contact details
Karen Allan :
Gartnavel General Hospital Campus
42 Shelley Court
Glasgow
G12 0XD